SHAKERI, A.; ADANTY, C. Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 27, n. 1, p. e25-e31, 2020. DOI: 10.15586/jptcp.v27i1.655. Disponível em: https://jptcp.com/index.php/jptcp/article/view/655. Acesso em: 16 jul. 2024.